Delhi-based mental healthtech startup InnerGize has raised ₹6.5 crore in a funding round led by Antler India and AC Ventures. The fresh capital will be directed towards manufacturing, research & development, clinical trials, and the official launch of its debut product, InnerGize Gen 1, slated for April 2025. Positioned as the world’s first clinically validated mental health wearable, InnerGize Gen 1 is designed to support individuals struggling with stress and anxiety. The device leverages a proprietary technology called Neuroacoustic Vagal Modulation, which activates the vagus nerve—the body’s natural relaxation switch—by sending soothing signals to the brain’s calm centers, helping reduce stress in a non-invasive, science-backed manner. With this innovation, InnerGize aims to bridge a significant gap in India’s mental healthcare ecosystem.
